TARGET-NASH: A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

  • STATUS
    Recruiting
  • sponsor
    TARGET Pharma Solutions
Updated on 23 November 2020

Summary

TARGET-NASH: A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

Description

Data collection on patients with NAFLD/NASH to determine the natural course of the liver disease and to determine if certain lifestyle changes or diet changes that may be recommended by your doctor can affect NAFLD/NASH. Optional blood samples may be collected once a year to identify and understand the genetic reasons why certain people respond differently to certain treatments and to identify biological markers.

For more information, please view the study on clinicaltrials.gov, https://clinicaltrials.gov/ct2/show/NCT02815891?term=target+nash&rank=1.

Details
Clinical Study IdentifierTX146651
SponsorTARGET Pharma Solutions
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Gender: Male or Female
Diagnosis of NAFLD, confirmed by imaging or histology
Diagnosis of NASH, confirmed by biopsy or confirmed by imaging with elevated liver enzymes and at least one of the following: obesity, type 2 diabetes, or dyslipidemia
No other chronic liver diseases
Cannot be participating in any other research studies for NAFLD/NASH treatment
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note